These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 10441488
1. Spatial organization of EGF receptor transmodulation by PDGF. Liu P, Anderson RG. Biochem Biophys Res Commun; 1999 Aug 11; 261(3):695-700. PubMed ID: 10441488 [Abstract] [Full Text] [Related]
2. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells. Zhong H, Minneman KP. Biochem J; 1999 Dec 15; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878 [Abstract] [Full Text] [Related]
3. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor. Shah BH, Olivares-Reyes JA, Catt KJ. Mol Pharmacol; 2005 Jan 15; 67(1):184-94. PubMed ID: 15465928 [Abstract] [Full Text] [Related]
6. Tyrosine phosphorylation of EGF-R and PDGF-R proteins during acute cutaneous wound healing process in mice. Gope ML, Gope R. Wound Repair Regen; 2009 Jan 15; 17(1):71-9. PubMed ID: 19152653 [Abstract] [Full Text] [Related]
8. Heterologous regulation of EGF receptors in fibroblastic cells. Olashaw NE, Pledger WJ. J Cell Biochem; 1987 Jun 15; 34(2):143-9. PubMed ID: 3496345 [Abstract] [Full Text] [Related]
9. The actin binding domain of the epidermal growth factor receptor is required for EGF-stimulated tissue invasion. van der Heyden MA, Van Bergen en Henegouwen PM, de Ruiter N, Verdaasdonk MA, van den Tweel JG, Rijksen G, Boonstra J, Joling P. Exp Cell Res; 1997 Aug 01; 234(2):521-6. PubMed ID: 9260923 [Abstract] [Full Text] [Related]
10. The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells. Goppelt-Struebe M, Fickel S, Reiser CO. Biochem J; 2000 Jan 15; 345 Pt 2(Pt 2):217-24. PubMed ID: 10620497 [Abstract] [Full Text] [Related]
11. Inhibitors of protein tyrosine phosphorylation: preliminary assessment of activity by time-resolved fluorescence. Amir-Zaltsman Y, Mazor O, Gayer B, Scherz A, Salomon Y, Kohen F. Luminescence; 2000 Jan 15; 15(6):377-80. PubMed ID: 11114114 [Abstract] [Full Text] [Related]
15. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Song L, Turkson J, Karras JG, Jove R, Haura EB. Oncogene; 2003 Jul 03; 22(27):4150-65. PubMed ID: 12833138 [Abstract] [Full Text] [Related]
16. Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression. Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A, Slomiany BL. Biochem Mol Biol Int; 1993 Aug 03; 30(6):1127-34. PubMed ID: 8106073 [Abstract] [Full Text] [Related]
17. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways. Huang L, Watanabe M, Chikamori M, Kido Y, Yamamoto T, Shibuya M, Gotoh N, Tsuchida N. Oncogene; 2006 Oct 19; 25(49):6457-66. PubMed ID: 16702953 [Abstract] [Full Text] [Related]